An Exploratory Study to Evaluate the Effect of Abatacept (BMS-188667) on the Antibody Response Following Tetanus Toxoid and 23-Valent Pneumococcal Vaccinations in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2011
At a glance
- Drugs Abatacept (Primary) ; Pneumococcal vaccine; Tetanus vaccine
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 11 Apr 2011 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 12 Sep 2008 New trial record.